Ambrilia Biopharma

Ambrilia Biopharma Inc. (TSX: AMB) is a biopharmaceutical company dedicated to the discovery and development of novel therapies for viral diseases and cancer. Ambrilia's broad pipeline includes proprietary mid- to early-stage products and new formulations of two existing drugs.